Literature DB >> 20739538

A determinant of Sindbis virus neurovirulence enables efficient disruption of Jak/STAT signaling.

Jason D Simmons1, Amy C Wollish, Mark T Heise.   

Abstract

Previous studies with Venezuelan equine encephalitis virus and Sindbis virus (SINV) indicate that alphaviruses are capable of suppressing the cellular response to type I and type II interferons (IFNs) by disrupting Jak/STAT signaling; however, the relevance of this signaling inhibition toward pathogenesis has not been investigated. The relative abilities of neurovirulent and nonneurovirulent SINV strains to downregulate Jak/STAT signaling were compared to determine whether the ability to inhibit IFN signaling correlates with virulence potential. The adult mouse neurovirulent strain AR86 was found to rapidly and robustly inhibit tyrosine phosphorylation of STAT1 and STAT2 in response to IFN-γ and/or IFN-β. In contrast, the closely related SINV strains Girdwood and TR339, which do not cause detectable disease in adult mice, were relatively inefficient inhibitors of STAT1/2 activation. Decreased STAT activation in AR86-infected cells was associated with decreased activation of the IFN receptor-associated tyrosine kinases Tyk2, Jak1, and Jak2. To identify the viral factor(s) involved, we infected cells with several panels of AR86/Girdwood chimeric viruses. Surprisingly, we found that a single amino acid determinant, threonine at nsP1 position 538, which is required for AR86 virulence, was also required for efficient disruption of STAT1 activation, and this determinant fully restored STAT1 inhibition when it was introduced into the avirulent Girdwood background. These data indicate that a key virulence determinant plays a critical role in downregulating the response to type I and type II IFNs, which suggests that the ability of alphaviruses to inhibit Jak/STAT signaling relates to their in vivo virulence potential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739538      PMCID: PMC2953173          DOI: 10.1128/JVI.00577-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

Review 1.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

2.  Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription.

Authors:  Natalia Garmashova; Rodion Gorchakov; Elena Frolova; Ilya Frolov
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 3.  JAK-STAT signaling: from interferons to cytokines.

Authors:  Christian Schindler; David E Levy; Thomas Decker
Journal:  J Biol Chem       Date:  2007-05-14       Impact factor: 5.157

4.  Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system.

Authors:  Rebeca Burdeinick-Kerr; Jennifer Wind; Diane E Griffin
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88.

Authors:  Asa S Hidmark; Gerald M McInerney; Eva K L Nordström; Iyadh Douagi; Kristen M Werner; Peter Liljeström; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.

Authors:  St Patrick Reid; Lawrence W Leung; Amy L Hartman; Osvaldo Martinez; Megan L Shaw; Caroline Carbonnelle; Viktor E Volchkov; Stuart T Nichol; Christopher F Basler
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression.

Authors:  Patricia V Aguilar; Scott C Weaver; Christopher F Basler
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

8.  The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.

Authors:  Natalia Garmashova; Rodion Gorchakov; Eugenia Volkova; Slobodan Paessler; Elena Frolova; Ilya Frolov
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

9.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus.

Authors:  Leonid Gitlin; Winfried Barchet; Susan Gilfillan; Marina Cella; Bruce Beutler; Richard A Flavell; Michael S Diamond; Marco Colonna
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-19       Impact factor: 11.205

10.  Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses.

Authors:  Reed S Shabman; Thomas E Morrison; Christopher Moore; Laura White; Mehul S Suthar; Linda Hueston; Nestor Rulli; Brett Lidbury; Jenny P-Y Ting; Suresh Mahalingam; Mark T Heise
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more
  26 in total

1.  The C-terminal domain of chikungunya virus nsP2 independently governs viral RNA replication, cytopathicity, and inhibition of interferon signaling.

Authors:  Jelke J Fros; Erika van der Maten; Just M Vlak; Gorben P Pijlman
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

Review 2.  Insect antiviral innate immunity: pathways, effectors, and connections.

Authors:  Megan B Kingsolver; Zhijing Huang; Richard W Hardy
Journal:  J Mol Biol       Date:  2013-10-09       Impact factor: 5.469

3.  Comparative protein profiling of B16 mouse melanoma cells susceptible and non-susceptible to alphavirus infection: Effect of the tumor microenvironment.

Authors:  Jelena Vasilevska; Gustavo Antonio De Souza; Maria Stensland; Dace Skrastina; Dmitry Zhulenvovs; Raimonds Paplausks; Baiba Kurena; Tatjana Kozlovska; Anna Zajakina
Journal:  Cancer Biol Ther       Date:  2016-09-16       Impact factor: 4.742

4.  A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Authors:  Thomas E Morrison; Lauren Oko; Stephanie A Montgomery; Alan C Whitmore; Alina R Lotstein; Bronwyn M Gunn; Susan A Elmore; Mark T Heise
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  Early events in alphavirus replication determine the outcome of infection.

Authors:  Ilya Frolov; Maryna Akhrymuk; Ivan Akhrymuk; Svetlana Atasheva; Elena I Frolova
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

6.  Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model.

Authors:  J J Ruotsalainen; M U Kaikkonen; M Niittykoski; M W Martikainen; C G Lemay; J Cox; N S De Silva; A Kus; T J Falls; J-S Diallo; F Le Boeuf; J C Bell; S Ylä-Herttuala; A E Hinkkanen; M J Vähä-Koskela
Journal:  Gene Ther       Date:  2014-09-18       Impact factor: 5.250

7.  Identification of Natural Molecular Determinants of Ross River Virus Type I Interferon Modulation.

Authors:  Adam Taylor; Suresh Mahalingam; Xiang Liu; Margit Mutso; Liubov Cherkashchenko; Eva Zusinaite; Lara J Herrero; Stephen L Doggett; John Haniotis; Andres Merits; Belinda L Herring
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

8.  Presentation overrides specificity: probing the plasticity of alphaviral proteolytic activity through mutational analysis.

Authors:  Valeria Lulla; Liis Karo-Astover; Kai Rausalu; Andres Merits; Aleksei Lulla
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

9.  MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.

Authors:  Miika Martikainen; Minna Niittykoski; Mikael von und zu Fraunberg; Arto Immonen; Susanna Koponen; Maartje van Geenen; Markus Vähä-Koskela; Erkko Ylösmäki; Juha E Jääskeläinen; Kalle Saksela; Ari Hinkkanen
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

Review 10.  Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation.

Authors:  Katherine S Forsyth; Laurence C Eisenlohr
Journal:  Curr Opin Immunol       Date:  2016-04-24       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.